The Roles of 3' and 4' Hydroxy Groups in Alpha-galactosylceramide Stimulation of Invariant Natural Killer T Cells

Overview

Journal ChemMedChem

Specialties Chemistry
Pharmacology

Date 2009 Sep 26

PMID 19780098

Citations 6

Authors

Chengfeng Xia

Wenpeng Zhang

Yalong Zhang

Wenlan Chen

Janos Nadas

Ryan Severin

Robert Woodward

Bin Wang

Xin Wang

Mitchell Kronenberg

Peng G Wang

Affiliations

Soon will be listed here.

Citing Articles

A Humanized Mouse Model Coupled with Computational Analysis Identifies Potent Glycolipid Agonist of Invariant NKT Cells.

Saavedra-Avila N, Pigni N, Caldwell D, Chena-Becerra F, Intano Jr J, Ng T ACS Chem Biol. 2024; 19(4):926-937.

PMID: 38477945 PMC: 11075374. DOI: 10.1021/acschembio.3c00736.

Cationic gold(I)-catalyzed glycosylation with glycosyl -1,1-dimethylpropargyl carbamate donors.

Gurung P, Thapa P, Lakshika Hettiarachchi I, Zhu J Org Biomol Chem. 2022; 20(35):7006-7010.

PMID: 36000552 PMC: 9540757. DOI: 10.1039/d2ob01436j.

Amide-Linked C4″-Saccharide Modification of KRN7000 Provides Potent Stimulation of Human Invariant NKT Cells and Anti-Tumor Immunity in a Humanized Mouse Model.

Saavedra-Avila N, Keshipeddy S, Guberman-Pfeffer M, Perez-Gallegos A, Saini N, Schafer C ACS Chem Biol. 2020; 15(12):3176-3186.

PMID: 33296161 PMC: 8323612. DOI: 10.1021/acschembio.0c00707.

Stimulation of natural killer T cells by glycolipids.

Anderson B, Teyton L, Bendelac A, Savage P Molecules. 2013; 18(12):15662-88.

PMID: 24352021 PMC: 4018217. DOI: 10.3390/molecules181215662.

Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.

Blumenfeld H, Tohn R, Haeryfar S, Liu Y, Savage P, Delovitch T Clin Exp Immunol. 2011; 166(1):121-33.

PMID: 21910729 PMC: 3193927. DOI: 10.1111/j.1365-2249.2011.04454.x.

References

Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y . KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res. 1995; 7(10-11):529-34. View

Fuji N, Ueda Y, Fujiwara H, Toh T, Yoshimura T, Yamagishi H . Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin Cancer Res. 2000; 6(8):3380-7. View

Li Z, Gildersleeve J . Mechanistic studies and methods to prevent aglycon transfer of thioglycosides. J Am Chem Soc. 2006; 128(35):11612-9. DOI: 10.1021/ja063247q. View

Koch M, Stronge V, Shepherd D, Gadola S, Mathew B, Ritter G . The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol. 2005; 6(8):819-26. DOI: 10.1038/ni1225. View

Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Rafii-El-Idrissi Benhnia M . Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol. 2006; 7(9):978-86. DOI: 10.1038/ni1380. View

Wun K, Borg N, Kjer-Nielsen L, Beddoe T, Koh R, Richardson S . A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med. 2008; 205(4):939-49. PMC: 2292230. DOI: 10.1084/jem.20072141. View

Hazlett L, Li Q, Liu J, McClellan S, Du W, Barrett R . NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J Immunol. 2007; 179(2):1138-46. DOI: 10.4049/jimmunol.179.2.1138. View

Sidobre S, Naidenko O, Sim B, Gascoigne N, Garcia K, Kronenberg M . The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol. 2002; 169(3):1340-8. DOI: 10.4049/jimmunol.169.3.1340. View

Wang J, Li J, Chen H, Chang H, Tanifum C, Liu H . Glycodiversification for the optimization of the kanamycin class aminoglycosides. J Med Chem. 2005; 48(20):6271-85. DOI: 10.1021/jm050368c. View

10.

Kronenberg M . Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005; 23:877-900. DOI: 10.1146/annurev.immunol.23.021704.115742. View

11.

Wu D, Zajonc D, Fujio M, Sullivan B, Kinjo Y, Kronenberg M . Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A. 2006; 103(11):3972-7. PMC: 1449630. DOI: 10.1073/pnas.0600285103. View

12.

Brossay L, Tangri S, Bix M, Cardell S, Locksley R, Kronenberg M . Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol. 1998; 160(8):3681-8. View

13.

Bendelac A, Rivera M, Park S, Roark J . Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol. 1997; 15:535-62. DOI: 10.1146/annurev.immunol.15.1.535. View

14.

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K . CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 1997; 278(5343):1626-9. DOI: 10.1126/science.278.5343.1626. View

15.

Spada F, Koezuka Y, Porcelli S . CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 1998; 188(8):1529-34. PMC: 2213414. DOI: 10.1084/jem.188.8.1529. View

16.

Hong S, Wilson M, Serizawa I, Wu L, Singh N, Naidenko O . The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-6. DOI: 10.1038/nm0901-1052. View

17.

Yang G, Schmieg J, Tsuji M, Franck R . The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angew Chem Int Ed Engl. 2004; 43(29):3818-22. DOI: 10.1002/anie.200454215. View

18.

Prigozy T, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A . Glycolipid antigen processing for presentation by CD1d molecules. Science. 2001; 291(5504):664-7. DOI: 10.1126/science.291.5504.664. View

19.

Naumov Y, Bahjat K, Gausling R, Abraham R, Exley M, Koezuka Y . Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A. 2001; 98(24):13838-43. PMC: 61128. DOI: 10.1073/pnas.251531798. View

20.

Borg N, Wun K, Kjer-Nielsen L, Wilce M, Pellicci D, Koh R . CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature. 2007; 448(7149):44-9. DOI: 10.1038/nature05907. View